Selective influence on contextual memory:: Physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the α5 subunit

被引:23
|
作者
Harris, Danni [1 ]
Clayton, Terry [2 ]
Cook, James [2 ]
Sahbaie, Peyman [1 ]
Halliwell, Robert F. [3 ]
Furtmueller, Roman [4 ]
Huck, Sigismund [4 ]
Sieghart, Werner [4 ]
DeLorey, Timothy M. [1 ]
机构
[1] Moltech Corp, Palo Alto, CA 94303 USA
[2] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA
[3] Univ Pacific, T J Long Sch Pharmacy & Hlth Sci, Stockton, CA 95211 USA
[4] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria
关键词
D O I
10.1021/jm701433b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ligands that bind to the benzodiazepine binding site on the GABA(A) receptor can attenuate or potentiate cognition. To investigate this property, the chemical determinants favoring selective binding or selective activation of the alpha 5 beta 2 gamma 2 and alpha 1 beta 2 gamma 2 GABA(A) receptor isoforms were examined. A 3D-pharmacophore, developed from a diverse set of BDZR ligands, was used as an initial basis for multivariate discriminant, fragment, and 3D-quantitative structure-activity relationship analyses, which formed the criteria for selection of additional compounds for study. We found that the electrostatic potential near the ligands' terminal substituent correlated with its binding selectivity toward the alpha 5 beta 2 gamma 2 versus alpha 1 beta 2 gamma 2 isoform; while the fragment length and frontier molecular orbital energetics correlated with a compounds influence on electrophysiological activity. Compounds with promising alpha 5 profiles were further assessed for their ability to attenuate scopolamine-induced contextual memory impairment in mice. Surprisingly, both weak inverse agonist and antagonists that display binding selectivity toward the alpha 5 beta 2 gamma 2 isoform were able to attenuate contextual memory impairment.
引用
收藏
页码:3788 / 3803
页数:16
相关论文
共 28 条
  • [21] An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze
    N. Collinson
    J. R. Atack
    P. Laughton
    G. R. Dawson
    D. N. Stephens
    Psychopharmacology, 2006, 188 : 619 - 628
  • [22] Combatting the opioid and benzodiazepine epidemic by the synthesis of novel safer drugs designed to be functionally selective for α5-or α6-containing GABAA receptors
    Knutson, Daniel
    Li, Guanguan
    Prevot, Thomas
    Arnold, Leggy
    Chiou, Lih-Chu
    Ernst, Margot
    Mihovilovic, Marko
    Savic, Miroslav
    Sieghart, Werner
    Sibille, Etienne
    Cook, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [23] In vivo labelling of α5 subunit-containing GABAA receptors using the selective radioligand [3H]L-655,708
    Atack, JR
    Alder, L
    Cook, SM
    Smith, AJ
    McKernan, RM
    NEUROPHARMACOLOGY, 2005, 49 (02) : 220 - 229
  • [24] GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085
    Garcia de Lucas, A.
    Ahring, P. K.
    Larsen, J. S.
    Rivera-Arconada, I.
    Lopez-Garcia, J. A.
    Mirza, N. R.
    Munro, G.
    BIOCHEMICAL PHARMACOLOGY, 2015, 93 (03) : 370 - 379
  • [25] The sedative but not the memory-blocking properties of ethanol are modulated by α5-subunit-containing γ-aminobutyric acid type A receptors
    Martin, Loren J.
    Zurek, Agnieszka A.
    Bonin, Robert P.
    Oh, Gabriel H. T.
    Kim, John H.
    Mount, Howard T. J.
    Orser, Beverley A.
    BEHAVIOURAL BRAIN RESEARCH, 2011, 217 (02) : 379 - 385
  • [26] Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABAA receptors which contain the alpha-5 subunit, in the elevated plus-maze test
    Navarro, JF
    Burón, E
    Martín-López, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (7-8): : 1389 - 1392
  • [27] Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site, of GABAA receptors which contain the alpha-5 subunit, in the elevated-plus maze test
    García, F
    Burón, E
    Martín, M
    Navarro, JF
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S333 - S334
  • [28] Evaluation of [methyl-3H]L655,708 and [ethyl-3H]RY80 as putative PET ligands for central GABAA receptors containing α5 subunit
    Opacka-Juffry, J
    Hirani, E
    Dawson, GR
    Luthra, SK
    Hume, SP
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (07) : 743 - 748